ARTICLE | Clinical News
Omigard: Completed Phase III enrollment
May 12, 2008 7:00 AM UTC
Cadence completed enrollment of about 1,850 patients in the double-blind, international Phase III CLIRS trial of topical Omigard. Last year, the company decided to increase enrollment from 1,250 patie...